Excellent news as the options for cancer treatment using more advanced targeted immuno-oncology treatment becomes closer to a possibility for European Countries.  Having vast experience in CAR-T and cell-based therapies, Karma Oncology supports the move away from traditional chemotherapy into the hot-topic field of immuno-oncology.  Link to article below: https://labiotech-eu.cdn.ampproject.org/c/s/labiotech.eu/car-t-cell-therapy-europe/amp/